These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32913987)

  • 1. Novel
    van der Leest C; Wagner A; Pedrosa RM; Aerts JG; Dinjens WNM; Dubbink HJ
    JCO Precis Oncol; 2018; 2():. PubMed ID: 32913987
    [No Abstract]   [Full Text] [Related]  

  • 2. Lung adenocarcinoma harboring rare epidermal growth factor receptor L858R and V834L mutations treated with icotinib: A case report.
    Zhai SS; Yu H; Gu TT; Li YX; Lei Y; Zhang HY; Zhen TH; Gao YG
    World J Clin Cases; 2020 Sep; 8(17):3841-3846. PubMed ID: 32953862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients.
    Hsu KH; Tseng JS; Wang CL; Yang TY; Tseng CH; Chen HY; Chen KC; Tsai CR; Yang CT; Yu SL; Su KY; Yu CJ; Ho CC; Hsia TC; Wu MF; Chiu KL; Liu CM; Yang PC; Chen JJ; Chang GC
    Oncotarget; 2016 Aug; 7(33):53299-53308. PubMed ID: 27449093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer.
    Ikeda K; Nomori H; Mori T; Sasaki J; Kobayashi T
    Ann Thorac Surg; 2008 Apr; 85(4):1430-2. PubMed ID: 18355544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer.
    Lu S; Yu Y; Li Z; Yu R; Wu X; Bao H; Ding Y; Shao YW; Jian H
    J Thorac Oncol; 2019 Apr; 14(4):732-736. PubMed ID: 30610926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma.
    Parry EM; Gable DL; Stanley SE; Khalil SE; Antonescu V; Florea L; Armanios M
    J Thorac Oncol; 2017 Nov; 12(11):1673-1678. PubMed ID: 28843361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients With Lung Adenocarcinoma.
    Lou Y; Pecot CV; Tran HT; DeVito VJ; Tang XM; Heymach JV; Luthra R; Wistuba II; Zuo Z; Tsao AS
    Clin Lung Cancer; 2016 Mar; 17(2):e5-11. PubMed ID: 26700910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited lung cancer syndromes targeting never smokers.
    Yamamoto H; Yatabe Y; Toyooka S
    Transl Lung Cancer Res; 2018 Aug; 7(4):498-504. PubMed ID: 30225213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma.
    Allo G; Bandarchi B; Yanagawa N; Wang A; Shih W; Xu J; Dalby M; Nitta H; To C; Liu N; Sykes J; Tsao MS
    Histopathology; 2014 May; 64(6):826-39. PubMed ID: 24251405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel use for an EGFR mutation-specific antibody in discriminating lung adenocarcinoma from reactive pneumocyte hyperplasia.
    Mimori T; Kobayashi S; Tanaka A; Sasada S; Yoshida A; Izumo T; Sasaki N; Tsuchida T; Tsuta K
    Histopathology; 2015 May; 66(6):816-23. PubMed ID: 25066097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma.
    Chen Z; Liu X; Zhao J; Yang H; Teng X
    Int J Clin Exp Pathol; 2014; 7(11):8039-45. PubMed ID: 25550848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between histopathologic characteristics and epidermal growth factor receptor mutation in lung adenocarcinoma].
    Wang K; Gong H; Li X; Yang Z; Cao P; Wand C; Jiang Y; Wang H; Wang Y; Zhang G
    Zhonghua Bing Li Xue Za Zhi; 2015 Mar; 44(3):170-4. PubMed ID: 26268750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinoma.
    Matsumura Y; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Muto S; Okabe N; Hasegawa T; Hoshino M; Osugi J; Higuchi M; Suzuki H
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):690-695. PubMed ID: 29049789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinoma.
    Yotsukura M; Yasuda H; Shigenobu T; Kaseda K; Masai K; Hayashi Y; Hishida T; Ohtsuka T; Naoki K; Soejima K; Betsuyaku T; Asamura H
    Lung Cancer; 2017 Jul; 109():45-51. PubMed ID: 28577949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent epidermal growth factor receptor mutation patterns between smokers and non-smokers with lung adenocarcinoma.
    Tseng JS; Wang CL; Yang TY; Chen CY; Yang CT; Chen KC; Hsu KH; Tsai CR; Chang GC
    Lung Cancer; 2015 Dec; 90(3):472-6. PubMed ID: 26474957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordance of Mutation Statuses of Epidermal Growth Factor Receptor and K-ras between Primary Adenocarcinoma of Lung and Brain Metastasis.
    Rau KM; Chen HK; Shiu LY; Chao TL; Lo YP; Wang CC; Lin MC; Huang CC
    Int J Mol Sci; 2016 Apr; 17(4):524. PubMed ID: 27070580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V843I, a lung cancer predisposing EGFR mutation, is responsible for resistance to EGFR tyrosine kinase inhibitors.
    Matsushima S; Ohtsuka K; Ohnishi H; Fujiwara M; Nakamura H; Morii T; Kishino T; Goto H; Watanabe T
    J Thorac Oncol; 2014 Sep; 9(9):1377-84. PubMed ID: 25057940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs).
    Zhong J; Li L; Wang Z; Bai H; Gai F; Duan J; Zhao J; Zhuo M; Wang Y; Wang S; Zang W; Wu M; An T; Rao G; Zhu G; Wang J
    J Thorac Oncol; 2017 Dec; 12(12):1766-1778. PubMed ID: 28818608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of the minor EGFR T790M mutation is associated with drug-sensitive EGFR mutations in lung adenocarcinoma patients.
    Hashida S; Soh J; Toyooka S; Tanaka T; Furukawa M; Shien K; Yamamoto H; Asano H; Tsukuda K; Hagiwara K; Miyoshi S
    Oncol Rep; 2014 Jul; 32(1):145-52. PubMed ID: 24842519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma.
    Kim Y; Shiba-Ishii A; Nakagawa T; Husni RE; Sakashita S; Takeuchi T; Noguchi M
    Pathol Int; 2017 Jun; 67(6):292-301. PubMed ID: 28544031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.